APBB2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.872200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.378600E-01
Normal-vs-Stage2
7.793200E-01
Normal-vs-Stage3
5.909200E-01
Normal-vs-Stage4
6.544000E-01
Stage1-vs-Stage2
4.048000E-01
Stage1-vs-Stage3
8.043800E-01
Stage1-vs-Stage4
3.168800E-01
Stage2-vs-Stage3
6.501200E-01
Stage2-vs-Stage4
1.942040E-01
Stage3-vs-Stage4
3.660200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.377600E-01
Normal-vs-AfricanAmerican
9.335200E-01
Normal-vs-Asian
5.736000E-01
Caucasian-vs-AfricanAmerican
7.654600E-01
Caucasian-vs-Asian
4.471400E-01
AfricanAmerican-vs-Asian
5.570200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.304400E-01
Normal-vs-Female
8.754000E-01
Male-vs-Female
4.283600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.413400E-01
Normal-vs-Age(41-60Yrs)
9.426200E-01
Normal-vs-Age(61-80Yrs)
7.290400E-01
Normal-vs-Age(81-100Yrs)
4.871400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.641800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.725400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.309400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.303390E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.085990E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.926400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.041600E-01
Normal-vs-Daily Drinker
2.456600E-01
Normal-vs-Weekly Drinker
9.257200E-01
Normal-vs-Occasional Drinker
9.955400E-01
Normal-vs-Social Drinker
7.484000E-01
Non Drinker-vs-Daily Drinker
6.535200E-01
Non Drinker-vs-Weekly Drinker
9.231800E-02
Non Drinker-vs-Occasional Drinker
2.609200E-01
Non Drinker-vs-Social Drinker
3.653800E-02
Daily Drinker-vs-Weekly Drinker
3.933800E-02
Daily Drinker-vs-Occasional Drinker
1.678840E-01
Daily Drinker-vs-Social Drinker
3.950300E-02
Weekly Drinker-vs-Occasional Drinker
9.101800E-01
Weekly Drinker-vs-Social Drinker
6.434600E-01
Occasional Drinker-vs-Social Drinker
6.144000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.692400E-01
Normal-vs-Grade 2
7.385400E-01
Normal-vs-Grade 3
3.841400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.506200E-02
Grade 1-vs-Grade 3
4.293800E-02
Grade 1-vs-Grade 4
7.692400E-01
Grade 2-vs-Grade 3
3.876600E-01
Grade 2-vs-Grade 4
7.385400E-01
Grade 3-vs-Grade 4
3.841400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.451200E-01
Normal-vs-NonDiabetic
7.534400E-01
Diabetic-vs-NonDiabetic
3.896800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.765600E-01
Normal-vs-NoPancreatitis
7.564800E-01
Pancreatitis-vs-NoPancreatitis
5.464200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.683800E-01
Normal-vs-N1
8.348200E-01
N0-vs-N1
6.015600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.190200E-01
Normal-vs-TP53-NonMutant
6.300600E-01
TP53-Mutant-vs-TP53-NonMutant
4.802400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
